certificate of analysis raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-07 and is reviewed periodically as new material appears.
Handling practices strongly affect measured purity and sample integrity. Many peptides are hygroscopic, susceptible to oxidation, or prone to adsorption on glass and plastic surfaces. Lyophilized powders are typically stored desiccated at -20 °C or below, while solutions may require colder storage and minimized freeze-thaw cycles. Peptides containing cysteine, methionine, or tryptophan can degrade through oxidation or disulfide exchange. Working aliquots reduce repeated exposure to moisture and temperature fluctuations during routine analysis.
Purity values do not necessarily predict biological potency. Net peptide content corrects for counterions such as acetate or trifluoroacetate, water, and residual salts. Impurity thresholds for reporting, identification, and qualification are often set according to regulatory guidance, though specific limits depend on the product class and route of administration. Open questions remain about the toxicological relevance of low-level peptide impurities and about how best to compare results across different analytical platforms. A certificate of analysis should state the methods used and the basis for each reported value.
Reverse-phase high-performance liquid chromatography is the most common primary method for peptide purity testing. The peptide mixture passes through a hydrophobic stationary phase, and components elute according to differences in hydrophobicity. A mobile phase of water and acetonitrile, often with trifluoroacetic acid as an ion-pairing agent, improves peak shape and retention. Ultraviolet detection at 214 nm records the peptide backbone absorbance, and the main peak area is divided by the total peak area to give an area-percent purity value.
Other chromatographic modes provide complementary information that reverse-phase separation may not capture. Ion-exchange chromatography separates peptides by net charge and can resolve deamidated, oxidized, or truncated variants that co-elute under hydrophobic conditions. Size-exclusion chromatography detects aggregates and higher-order oligomers, which are often invisible in reverse-phase assays. Chiral chromatography can quantify D-amino acid epimers when stereochemical purity matters. Because each mode uses a different separation principle, a single purity number from one method cannot describe all possible impurities.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | For lyophilized powder; desiccant and light protection are common. |
| Appearance | White to off-white powder | Visual description alone does not establish purity or identity. |
| Solubility class | Often freely soluble in water | Depends on sequence; hydrophobic peptides may require organic co-solvents. |
| Water content method | Karl Fischer titration | Measures residual moisture that affects net peptide content. |
| Counterion method | Ion chromatography | Quantifies acetate, chloride, trifluoroacetate, and related ions. |
Quality control for peptides places purity testing within a documented system that includes specifications, test methods, and acceptance criteria. A certificate of analysis typically reports appearance, chromatographic purity, mass confirmation, and storage conditions. System suitability checks, blank injections, and reference standards help ensure that an analytical run is valid. Traceability requires records of sample preparation, instrument settings, and data processing. No single purity threshold applies to all peptides or uses, so specifications are set according to the intended application and risk assessment.
Sampling and sample preparation influence measured purity. Peptides are often hygroscopic, so weighing should occur quickly under controlled humidity to avoid water uptake. Complete dissolution in a suitable solvent is necessary before injection; undissolved material can block columns or distort results. Filtration removes particulates but may also remove aggregates if the filter pore size is too small. Impurities can originate from synthesis, cleavage, purification, or storage, and forced degradation under heat, light, oxidation, or pH extremes can help identify degradation pathways.
Regulatory and accreditation expectations depend on the peptide's intended use. Research reagents may be tested with in-house methods, while pharmaceutical development follows validated procedures and pharmacopeial chapters where applicable. Method validation commonly examines accuracy, precision, specificity, linearity, range, and limits of detection and quantitation. Laboratories accredited to ISO/IEC 17025 must document competence, equipment calibration, and uncertainty. Comparing purity results across laboratories remains difficult because different columns, gradients, detection wavelengths, and integration rules can change reported values; open questions include how best to standardize impurity identification and reporting for diverse peptide products.
Quality control for peptide products relies on written procedures, batch records, and certificates of analysis. A certificate of analysis typically lists the test methods, specifications, and results for a specific lot. Batch records document synthesis, purification, and testing steps so that results can be traced to process conditions. Method validation establishes accuracy, precision, specificity, linearity, and limits of detection. These records support consistency across lots and allow laboratories to investigate deviations when a specification is not met.
Storage conditions influence purity and therefore testing outcomes. Lyophilized peptides are generally kept cool and dry, while solutions may require refrigeration or freezing depending on sequence and buffer. Repeated freeze-thaw cycles can promote aggregation, oxidation, or hydrolysis. Testing after storage should use the same validated method as release testing to allow comparison. Stability studies examine how purity changes over time under defined temperature and humidity conditions. Results are compared against baseline data collected at release.
== Geschichte == Im Jahr 2009 wurde das Deutsche Zentrum für Diabetesforschung in der Rechtsform eines Vereins gegründet. Das DZD besteht aus fünf gleichberechtigten wissenschaftlichen Forschungseinrichtungen, den fünf Partnern. Partner im DZD sind:
Deutsches Diabetes-Zentrum in Düsseldorf Deutsches Institut für Ernährungsforschung in Potsdam-Rehbrücke Helmholtz Munich in München / Neuherberg Institut für Diabetesforschung und Metabolische Erkrankungen von Helmholtz Munich an der Eberhard-Karls-Universität Tübingen in Tübingen Paul Langerhans Institut Dresden von Helmholtz Munich am Universitätsklinikum und der Medizinischen Fakultät Carl Gustav Carus der TU Dresden in Dresden Das DZD hat 450 Mitarbeiter. Im Jahr 2023 lag das Budget bei 23 Mio. Euro. Das DZD wird zu 90 Prozent vom Bund und zu 10 Prozent von den Bundesländern finanziert, die Sitz der DZD-Standorte sind. Fünf assoziierte Partner an den Universitäten in Heidelberg, Köln, Leipzig, Lübeck und München sowie sieben Projektpartner erweitern das Kompetenzspektrum des DZD.
== Schwerpunkte der Forschung == Im Deutschen Zentrum für Diabetesforschung (DZD) arbeiten deutschlandweit mehr als 450 universitäre und außeruniversitäre Wissenschaftlerinnen und Wissenschaftler interdisziplinär an neuen, präzisen Präventions- und Therapiekonzepten für Diabetes mellitus. Die Forschenden kooperieren standortübergreifend in sieben Forschungsschwerpunkten (Akademien). Die Akademien widmen sich den folgenden Themen:
Sources: de.wikipedia.org
== Wichtige Ergebnisse (Auswahl) == Mit dem Diabetes-Risiko-Test® können Erwachsene ihr Risiko bestimmen, innerhalb der kommenden zehn Jahren an Typ-2-Diabetes zu erkranken. Schiborn C, Paprott R, Heidemann C, Kühn T, Fritsche A, Kaaks R, Schulze MB: German diabetes risk score for the determination of the individual type 2 diabetes risk—10-year prediction and external validations. Dtsch Arztebl Int 2022; 119: 651–7. doi:10.3238/arztebl.m2022.0268 Mühlenbruch K, ..., Schulze MB. Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study. Diabetes Res Clin Pract. 2014 Jun;104(3):459-66. doi:10.1016/j.diabres.2014.03.013. Epub 2014 Mar 28. PMID 24742930 Schiborn C, ..., Schulze MB. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population. Sci Rep. 2021 Oct 4;11(1):19609. doi:10.1038/s41598-021-99103-4. PMID 34608230; PMCID: PMC 8490374 (freier Volltext) Forschende des DZD haben eine neue Wirkstoffklasse (Polyagonisten) für Medikamente zur Behandlung von Diabetes und schwerem Übergewicht entwickelt, die gleich mehrere Hormone kombiniert. Der erste Vertreter dieser neuen Medikamentenklasse ist bereits in den USA und Europa zur Behandlung von Typ-2-Diabetes und Adipositas zugelassen. Finan B., ..., Tschöp MH. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013 Oct 30;5(209):209ra151. doi:10.1126/scitranslmed.3007218. PMID 24174327 Finan B, ..., Tschöp MH.
Sources: de.wikipedia.org
Lyophilized peptides are generally stored desiccated at -20 °C or lower, protected from light and moisture. Solutions are often kept at -80 °C in aliquots to limit freeze-thaw damage. Specific sequences may require different conditions based on oxidation or aggregation risk.
No, high chromatographic purity does not ensure correct three-dimensional structure or biological function. Activity also depends on sequence integrity, post-translational modifications if relevant, and assay conditions. Purity testing measures chemical composition rather than potency.
Counterion content refers to the mass of ions such as acetate, chloride, or trifluoroacetate that remain associated with a peptide after synthesis and purification. These ions can contribute substantially to sample mass and affect net peptide content. Analytical methods for counterions include ion chromatography and capillary electrophoresis.
HPLC purity measures the relative area of the main peptide peak compared with all detected peaks under one set of separation and detection conditions. It is an operational value rather than an absolute mass fraction. Compounds that do not absorb at the detection wavelength or that co-elute with the main peak are not counted.